A Fast Capillary Electrophoresis Method for Separation and Quantification of Modified Nucleosides in Urinary Samples
Authors:
- 24 June 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 81 (15) , 6474-6480
Abstract
Modified nucleosides are formed at the post-transcriptional stage by chemical modification of normal nucleosides within the ribonucleic acid (RNA). These modified nucleosides cannot be reutilized or further degraded, but they are excreted in the urine as intact molecules. The elevated levels of modified nucleosides in the urine samples have served as potential cancer biomarkers in many studies. Although different analytical techniques have been reported for determining nucleosides levels, they are practically difficult to use as a routine tool for early cancer screening. In this paper, a novel method was developed to separate and quantify 10 nucleosides—adenosine, cytidine, guanosine, uridine, inosine, xanthosine, pseudouridine, N2-methylguanosine, 1-methyladenosine, and N2,N2-dimethylguanosine—in urine samples using capillary electrophoresis with an ultraviolet (UV) detector (abbreviated as CE-UV) at a wavelength of 254 nm. A 50 μm (i.d.) × 38 cm (effective length) fused silica capillary was used for the separation, and a borate−phosphate buffer containing 25 mM cetyltrimethylammonium bromide (CTAB) at pH 9.50 was used as a background electrolyte. The separation was performed at 15 kV under reverse polarity and completed within 10 min. The linear range of the analytes was 5.0−500 μmol/L, and the limit of detection was <2.0 μmol/L. The effects of pH, buffer concentrations, CTAB concentration, and the operation voltages on the separation and quantification of the modified nucleosides were also investigated. The technique developed in this study is much simpler and faster, compared to previous studies, and can be used to quantify modified nucleosides in urine samples.Keywords
This publication has 30 references indexed in Scilit:
- Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancerAnalytica Chimica Acta, 2008
- Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patientsBiomarkers, 2008
- Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoringJournal of Gastroenterology and Hepatology, 2005
- Urinary nucleosides as biological markers for patients with colorectal cancerWorld Journal of Gastroenterology, 2005
- Clinical significance and prognostic value of urinary nucleosides in breast cancer patientsClinical Biochemistry, 2005
- Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseasesJournal of Chromatography B, 2004
- Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from thyroid cancer patientsAnalytica Chimica Acta, 2003
- Analysis of urinary nucleosides. III. Identification of 5′‐deoxycytidine in urine of a patient with head and neck cancerRapid Communications in Mass Spectrometry, 2003
- Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from uterine myoma and cervical cancer patientsJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Breast cancer prognostic significance of some modified urinary nucleosidesCancer Letters, 1996